NEW YORK, February 26, 2018 /PRNewswire/ --
BUCM expertise will help enrich and enhance existing Elsevier content; opening new resources up to users as research and evidence about traditional Chinese medicine grows
As global interest in traditional and alternative medicine grows, Elsevier, the global information analytics business specializing in
Currently valued at 786 billion yuan (approx. $121 billion USD), the TCM market is growing, with pharmaceutical companies becoming interested in developing and verifying the benefits of TCM. Despite having been practiced for thousands of years, research into TCM can present some modern challenges. Although TCM literature from the historical period and from modern clinical studies has recently been digitized in relational databases or text documents, searching and retrieving the precise evidence using abstract and indexing databases remains a challenge. Further, TCM relies on numerous spellings, synonyms, translations, and symbols - with multiple ways to refer to the same medicine. The new taxonomy will cover a variety of branches, including the 'up' branch, 'narrow' branch and 'children' structure of TCM, enabling researchers to search for any of the compounds which may make up traditional Chinese medicines and discover linked results.
"The trend in the use of traditional and complementary medicine is growing globally, and as a result, the volume of published resources into this field is increasing at a rate of around 6 percent per year, with more than 10,000 scholarly research or review articles published in 2017 alone," said Cameron Ross, Managing Director of Life Science Solutions at Elsevier. "According to World Health Organization (WHO) estimates, more than 100 million Europeans are currently using traditional and complimentary medicines, with many more users in Africa, Asia, Australia and North America.
"In response to these market demands and the expectations of our customers, we are working with BUCM to build a taxonomy for Chinese medicine that will help our clients examine specific TCM practices from a scientific perspective," Mr. Ross added. "By enabling this discovery and analysis of integrated health and medical research, we can provide our customers with more successful outcomes and a deeper understanding of the evidence behind how TCM complements conventional medicine to improve prospects for patients."
Beijing University of Chinese Medicine is one of the top ranking Chinese universities, with a long heritage of, and experience in, teaching TCM. The university is also involved in the Cochrane Collaboration, a global independent network of researchers, professionals, patients, carers and individuals interested in health. As part of the Cochrane China Group, BUCM is dedicated to publishing high evidence-based practices, which, along with its vast experience of TCM, makes it a great collaborator to help make Embase's TCM data more widely discoverable. The taxonomies will be provided in English, and researchers will be able to search the spelling of Chinese characters as part of the new taxonomies, which will be live in Embase in early 2019.
"BUCM has been working in the field of traditional Chinese medicine for over 60 years, building a deep knowledge of the domain," said Professor Jianping Liu, Director, Centre for Evidence-Based Chinese Medicine at Beijing University of Chinese Medicine. "We recognize the increasing interest in TCM and traditional medicines more generally and are extremely pleased to be able to share our knowledge with a wider audience through Embase. We are excited at this opportunity to further the field of TCM beyond the 313,000 professionals who have studied at BUCM. This is a chance for us to promote scientific research and evidence-based practice of TCM in China and around the world, while helping researchers globally to develop further the understanding of TCM as a medical science, useful for both the prevention and the treatment of disease."
Embase is Elsevier's biomedical literature database allowing researchers to access the biomedical research they need quickly and accurately. It has over 32 million records from almost 8,300 published journals. Embase contains a wide range of comprehensive, evidence-based medicine, drug and medical device efficacy studies. Embase is supported by Emtree, a hierarchically structured, controlled vocabulary for Biomedicine and related Life Sciences. As of 2017, Emtree contained over 75,000 preferred terms (more than 32,000 for drugs and chemicals) and over 320,000 synonyms.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, Scival, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
Christopher Capot, Global Communications
Elsevier +1-917-704-5174 email@example.com
Jason Chan, Global Communications, Asia Pacific
Elsevier +65-9177-8358 firstname.lastname@example.org
 Source: Scopus mentions of traditional, complimentary or alternative medicine, conducted January 2018
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All